Newsfeeds - Spark Newswire

1 minute read

Johnson & Johnson’s Upcoming Lung Cancer Data Could Offer Another Blockbuster Opportunity, Says Analyst

Today, 6:48 AM

Cantor Fitzgerald is previewing its thoughts on a potential interim analysis for Johnson & Johnson’s (NYSE:JNJ) Phase 3 MARIPOSA study of Rybrevant (amivantamab)…

AZN

1 minute read

Biden Pledges Veto If Congress Passes Bill To Eliminate COVID-19 Vaccine Mandate On Health Care Providers Working On Certain Federal Programs

By Michael Horton

Today, 6:48 AM

-Reuters

AZN

1 minute read

Biden Administration Plans To End Emergency Declarations On COVID-19 On May 11

By Michael Horton

Today, 6:48 AM

-Reuters

AZN

1 minute read

Legal
News

Johnson & Johnson’s Talc Bankruptcy Case Dismissed By Appeals Court; J&J Talc Unit Wasn’t In Financial Distress, Appeals Court Says – WSJ

By Happy Mohamed

Today, 6:48 AM

- Dow Jones Citing WSJ

JNJ

2 minute read

$1,000 Invested In 4 Of The 5 Vaccine Developers Back When WHO Declared COVID-19 An Emergency Yielded Returns

By Shanthi Rexaline

Today, 6:48 AM

The COVID-19 pandemic emerged in 2019 in China and spread to the rest of the globe in early 2020. Since then, the virus has caused more than 6.8 million deaths.

AZN

4 minute read

Nasdaq Futures Slump As Microsoft’s Outlook Dampens Tech Recovery Hopes — Analyst Warns Of More Bumpiness By Mid-February

By Shanthi Rexaline

Today, 6:48 AM

U.S. stocks look set to start Wednesday’s session on the back foot as traders digest mixed earnings news flow and continued pouring in of weak economic data points. Cues From Tuesday’s Trading:

ABT

1 minute read